Vinca alkaloids and taxanesDownloads

A 32-year-old man presents with a 1-week history of progressive diplopia followed by numbness and tingling in his hands and feet, some weakness in his extremities, and occasional difficulty swallowing. He was recently diagnosed with Hodgkin's lymphoma and started on a chemotherapeutic regimen that included bleomycin, doxorubicin, cyclophosphamide, vincristine, and prednisone. He denies fever, recent viral illness, or vaccination. On neurological examination, he has bilateral ptosis. His bilateral pupils are 5 mm in diameter and poorly responsive to light and accommodation. He has a bilateral facial weakness and his gag reflex is reduced. Motor examination using the Medical Research Council scale reveals a muscle strength of 4/5 in the proximal muscles of upper extremities bilaterally and 2/5 in distal muscles. In his lower extremities, hip muscles are mildly weak bilaterally, and he has bilateral foot drop. Deep tendon reflexes are absent. Sensory examination reveals a stocking-pattern loss to all sensory modalities in the lower extremities up to the middle of his shins. A brain MRI is normal. Lumbar puncture is unremarkable. His condition can be explained by a common adverse effect of which of the following drugs?

A 57-year-old woman with non-small cell lung cancer comes to the physician 4 weeks after her tumor was resected. She takes no medications. The physician starts her on a treatment regimen that includes vinblastine. This treatment puts the patient at highest risk for which of the following?